Evidence mapPaperPMID 41765417Full record

ArticleBrain pathology (Zurich, Switzerland)2026

Amyloid-β aggregates induce vasculopathy via ferroptosis in brain endothelial cells.

Suhyeon Son, Suji Kim, Min-Tae Jeon, Moonseok Choi, Kyu-Sung Kim, Suji Lee, Seung-Yeol Nah, Do-Geun Kim

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Suhyeon SonDementia Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.
Suji KimDementia Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.
Min-Tae JeonDementia Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.
Moonseok ChoiDementia Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.
Kyu-Sung KimDementia Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.
Suji LeeDementia Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.
Seung-Yeol NahGinsentology Research Laboratory and Department of Physiology, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea.
Do-Geun KimDementia Research Group, Korea Brain Research Institute, Daegu, Republic of Korea.ORCID https://orcid.org/0000-0002-0066-884X

Funding

Korea Brain Research Institute 25-BR-02-03Korea Brain Research Institute 25-BR-08-01Korea Dementia Research Center RS-2023-KH135534Korea Dementia Research Center RS-2023-KH-138465National Research Foundation of Korea 2021R1C1C1011427National Research Foundation of Korea GLT-25071-100National Research Foundation of Korea RS-2024-00508681
6 · The paper itself

Abstract

Amyloid-β (Aβ) plaque is the defining pathological feature of Alzheimer's disease (AD) and a target of various therapeutic agents for affected patients. Recent studies have demonstrated the dysfunction of the blood-brain barrier (BBB) in AD; however, how Aβ plaque induces BBB dysfunction, particularly in brain endothelial cells (ECs), remains elusive. This study investigates the lipid peroxidation-mediated ferroptosis pathway induced by Aβ via conducting RNA sequencing, phosphorylation analysis, metabolite analysis, western blotting, and immunofluorescent staining both in vitro and in vivo. Here, we demonstrate that Aβ is associated with lipid metabolic pathways following Aβ exposure in brain ECs. Additionally, Aβ aggregates induce the formation and accumulation of peroxidized lipid droplets. Lastly, Aβ is significantly reduced in brain ECs and 5xFAD mice by the inhibition of the lipid metabolic pathway associated with lipid peroxidation and ROS formation. Our findings from in vitro and in vivo both suggest that Aβ plays a causative role in the process of lipid peroxidation and might provide a potential target for the development of therapeutic interventions for AD.

Indexed as

Amyloid beta-PeptidesBrainEndothelial CellsFerroptosisAlzheimer DiseaseAnimalsBlood-Brain BarrierDisease Models, AnimalHumansLipid PeroxidationMiceMice, TransgenicPlaque, AmyloidReactive Oxygen SpeciesAmyloid beta-PeptidesReactive Oxygen Speciesamyloid‐βblood–brain barrierferroptosislipid dropletslipid peroxidation

Identifiers

PMID41765417
PMCPMC13240017

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.